N Lynn Henry Selected Research

Aromatase Inhibitors

2/2024	Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms.
1/2024	Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer.
11/2022	Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.
10/2022	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.
12/2021	Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
1/2021	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.
1/2021	Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias.
1/2021	Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors.
1/2021	Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer.
1/2020	Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Lynn Henry Research Topics

Disease

103	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2006
35	Neoplasms (Cancer) 02/2024 - 01/2006
16	Pain (Aches) 01/2023 - 09/2008
11	Peripheral Nervous System Diseases (PNS Diseases) 11/2023 - 01/2018
7	Arthralgia (Joint Pain) 11/2022 - 09/2010
3	Circulating Neoplastic Cells 01/2022 - 06/2015
3	Hot Flashes 12/2021 - 07/2009
3	Chronic Pain 01/2018 - 12/2011
2	Dihydropyrimidine Dehydrogenase Deficiency 12/2023 - 01/2022
2	Vitamin D Deficiency 11/2023 - 04/2020
2	Alopecia (Baldness) 10/2022 - 01/2022
2	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2021 - 11/2021
2	Neoplasm Metastasis (Metastasis) 02/2021 - 08/2012
2	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 11/2019
2	Fatigue 01/2018 - 08/2014
2	Syndrome (Syndromes) 01/2016 - 08/2014
2	Hypertension (High Blood Pressure) 01/2016 - 07/2015
2	Musculoskeletal Pain 08/2014 - 05/2011
1	Squamous Cell Carcinoma of Head and Neck 02/2024
1	Hypersensitivity (Allergy) 11/2023
1	Fibromyalgia (Fibrositis) 01/2023
1	Frailty 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Microsatellite Instability 01/2022
1	Thrombosis (Thrombus) 12/2021
1	Osteoarthritis 12/2021
1	Osteonecrosis (Kienbock's Disease) 02/2021
1	Pathologic Complete Response 12/2020
1	Uterine Neoplasms (Uterine Cancer) 11/2020
1	Exanthema (Rash) 07/2020
1	Lung Neoplasms (Lung Cancer) 07/2020
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2020
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

37	Hormones (Hormone)IBA 04/2024 - 01/2006
35	Aromatase InhibitorsIBA 02/2024 - 09/2008
16	Letrozole (Femara)FDA LinkGeneric 10/2022 - 09/2008
15	exemestane (Aromasin)FDA Link 10/2022 - 09/2008
13	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 01/2018
13	Estrogen ReceptorsIBA 01/2022 - 01/2012
10	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2011
7	Tamoxifen FDA LinkGeneric 01/2023 - 10/2009
6	Estrogens (Estrogen)FDA Link 01/2019 - 05/2014
5	Anastrozole (Arimidex)FDA LinkGeneric 04/2024 - 04/2017
5	human ERBB2 proteinIBA 01/2022 - 06/2015
4	ametantrone (HAQ)IBA 04/2024 - 09/2008
4	ErbB Receptors (EGF Receptor)IBA 03/2024 - 10/2014
4	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 11/2015
4	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2021 - 12/2011
3	Fulvestrant (Faslodex)FDA Link 03/2024 - 01/2016
3	AnthracyclinesIBA 01/2022 - 07/2015
3	Formaldehyde (Formol)FDA Link 01/2019 - 11/2015
3	ParaffinIBA 01/2019 - 11/2015
3	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 06/2006
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2012 - 10/2009
2	Circulating Tumor DNAIBA 02/2024 - 01/2022
2	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 11/2021
2	Vitamin D FDA LinkGeneric 11/2023 - 04/2020
2	salicylhydroxamic acid (SHAM)IBA 11/2022 - 10/2018
2	taxaneIBA 10/2022 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 12/2020 - 08/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 12/2011
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 12/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2016 - 07/2015
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2016 - 01/2016
1	capivasertibIBA 03/2024
1	Taxoids (Taxanes)IBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	dostarlimabIBA 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022
1	pembrolizumabIBA 01/2022
1	AlpelisibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	Capecitabine (Xeloda)FDA Link 11/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021
1	Zoledronic Acid (Zometa)FDA Link 02/2021
1	Lapatinib (GW572016)FDA Link 12/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2020
1	HomocysteineIBA 04/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2020
1	ORALIT (ORS)IBA 11/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2018
1	Threonine (L-Threonine)FDA Link 10/2018

Therapy/Procedure

58	Therapeutics 03/2024 - 01/2006
26	Drug Therapy (Chemotherapy) 01/2024 - 11/2006
7	Adjuvant Chemotherapy 11/2022 - 01/2006
4	Radiotherapy 07/2023 - 07/2015
3	Aftercare (After-Treatment) 01/2023 - 12/2011
2	Neoadjuvant Therapy 01/2023 - 12/2020
1	Polypharmacy 01/2024
1	Time-to-Treatment 10/2022
1	Immunotherapy 01/2022
1	Integrative Oncology 10/2021
1	Complementary Therapies (Alternative Medicine) 10/2021
1	Mastectomy (Mammectomy) 05/2021
1	Dental Care 02/2021
1	Salpingo-oophorectomy 11/2019